HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587
Open Access
- 17 March 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (6), 1371-1376
- https://doi.org/10.1016/0006-2952(92)90515-k
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudineAntimicrobial Agents and Chemotherapy, 1991
- DNA Polymerases versus HIV Reverse Transcriptase in AIDS TherapyAnnals of the New York Academy of Sciences, 1990
- Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase InhibitorScience, 1990
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineJournal of Medicinal Chemistry, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1986
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983